- Free Consultation 24/7: (800) 337-7755 Tap Here to Call Us
Vision Loss After Ozempic or Another GLP-1 Drug? You May Qualify for a Lawsuit

A GLP-1 blindness lawsuit may be an option for people who developed sudden vision loss, such as NAION, while taking a GLP-1 drug like Ozempic, Wegovy, Mounjaro or Zepbound. Pending lawsuits allege the drug makers failed to warn patients and doctors about this risk. Whether someone qualifies can depend on the diagnosis, timing, medical records and filing deadlines.
If you or a loved one lost vision while taking a GLP-1 medication, call the Law Offices of Jason Turchin at 800-337-7755 for a free case review.
GLP-1 Vision Loss Claims at a Glance
| Question | Short answer |
|---|---|
| What eye condition is involved? | Most claims involve NAION, a form of optic neuropathy caused by reduced blood flow to the optic nerve. |
| Which drugs are named? | Lawsuits may involve GLP-1 drugs, including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). |
| What do the lawsuits allege? | They allege the makers failed to adequately warn patients and doctors about the risk of serious harm. |
| Has causation been proven? | No. The drug makers dispute the claims, and courts are still weighing the scientific evidence. |
| Is there a filing deadline? | Yes. Florida and other states set time limits, so waiting can put a claim at risk. |
How One Patient’s Story Brought Attention to GLP-1 Vision Loss
NPR recently reported on a Maryland man who had operated heavy machinery for four decades. In early 2023, his doctor prescribed Ozempic for diabetes. That New Year’s Eve, he woke up unable to see out of his right eye. He described it as dark and black, as if a patch covered it.
His doctor diagnosed NAION, an inoperable condition. When his wife asked whether Ozempic could be a cause, the doctor said they had heard nothing about that. Seven months later, the journal JAMA Ophthalmology published research showing higher rates of NAION among diabetic patients taking semaglutide. Neither the man nor his doctor knew about it, so he kept taking his weekly shots until his left eye also went dark. He has since filed a lawsuit alleging Novo Nordisk failed to warn about the risk, according to reports.
What Is NAION, and Why Is It Linked to GLP-1 Drugs?
NAION (non-arteritic anterior ischemic optic neuropathy) is a condition in which reduced blood flow damages the optic nerve, often causing sudden, painless vision loss in one eye. Some research has found higher rates of NAION in people taking semaglutide, which is why it has become the focus of many GLP-1 claims.
It is important to understand what that research does and does not show. After the JAMA Ophthalmology study, the American Academy of Ophthalmology and the North American Neuro-Ophthalmology Society issued a consumer clarification stating, “This is not the type of study that can show the treatment caused NAION.” The groups acknowledged a potential link but said more research is needed, and they did not recommend that patients stop their medication. The FDA has told NPR it is conducting its own study of NAION risks.
According to NPR’s review of the FDA’s adverse event database, there were more than 1,000 reports of optic neuropathy linked to GLP-1s since 2024. Those reports are voluntary and unverified, but they are one way regulators spot possible problems.
Which GLP-1 Drugs Are Involved in the Litigation?
The lawsuits involve GLP-1 drugs from two main manufacturers. Many people know these medications only by brand name, so this table may help you match your prescription to its maker.
| Brand name | Active ingredient and maker |
|---|---|
| Ozempic | Semaglutide, made by Novo Nordisk |
| Wegovy | Semaglutide, made by Novo Nordisk |
| Mounjaro | Tirzepatide, made by Eli Lilly |
| Zepbound | Tirzepatide, made by Eli Lilly |
According to NPR, the two main consolidated federal cases include 247 plaintiffs with NAION and thousands more alleging digestive injuries. You can learn more on our Ozempic injury lawsuit page.

Who May Qualify for a GLP-1 Blindness Lawsuit?
You may qualify if you were diagnosed with NAION or another serious vision loss after taking a GLP-1 drug and the timing and medical evidence support a possible connection. Each case is different, and an attorney can review your records to see whether a claim may be possible.
Factors that may matter include:
- A documented diagnosis: NAION or optic neuropathy confirmed by an eye doctor or neuro-ophthalmologist.
- Proof of the prescription: pharmacy or medical records showing which GLP-1 you took and when.
- Timing of symptoms: vision loss that began while you were taking the drug or soon after.
- Your warnings: whether you or your doctor were told about any vision risk.
- Other health factors: conditions like diabetes or high blood pressure, which the defense may point to.
Examples of Situations That May Lead to a Claim
The following examples are hypothetical and are shown only to illustrate the kinds of situations people bring to us. They are not actual cases or results.
- Sudden loss in one eye: A Broward County retiree taking Wegovy for weight loss wakes with blurred, dim vision in one eye and is later diagnosed with NAION.
- Vision loss in both eyes: A man with diabetes loses sight in one eye on Ozempic, keeps taking it because no one mentioned a possible link, and later loses vision in the other eye.
- A loss of livelihood: A delivery driver on Mounjaro loses partial vision and can no longer hold a commercial license or work.
What Should You Do If You Lost Vision While Taking a GLP-1?
Your first priority is medical care, followed by preserving the records that can support a claim. Talk with your doctor before stopping or changing any medication.
- See an eye doctor promptly and ask for a written diagnosis.
- Tell your prescribing doctor about your vision changes.
- Keep your pens, packaging and pharmacy labels.
- Request copies of your pharmacy and medical records.
- Write down when symptoms started and how they have affected work and daily life.
- Speak with an experienced drug injury attorney before talking to any drug company or insurer.
Is There a Deadline to File a GLP-1 Vision Loss Claim?
Yes. Every state limits how long you have to file a lawsuit, and missing the deadline can bar a claim entirely. In Florida, Florida Statute §95.11 sets time limits for filing many civil claims, and the deadline that applies to you may depend on when you learned of your injury and its possible cause. Because these rules can be complicated, it may help to speak with a lawyer as soon as possible.
Why Choose the Law Offices of Jason Turchin
Attorney Jason Turchin founded the Law Offices of Jason Turchin, a personal injury firm based in Weston, Florida, and represents people hurt by dangerous drugs and defective products. He holds an AV Preeminent Peer Rated for Highest Level of Professional Excellence by Martindale-Hubbell in 2026 and received the Martindale-Hubbell Client Champion Platinum Award in 2026. He has been named to the Super Lawyers list from 2020 through 2026, and the firm has held an A+ BBB rating annually from 2014 through 2026.
The firm handles personal injury cases in Florida, New York, New Jersey and Washington, D.C., and throughout the U.S. with a network of co-counsels and local counsels. Cases are handled on a contingency fee basis, with fees and costs waived if there is no recovery. Learn more about Attorney Jason Turchin.
GLP-1 Blindness Lawsuit FAQs
Can Ozempic cause blindness?
Some studies have found higher rates of NAION among people taking semaglutide, but medical groups say those studies do not prove the drug causes it. Courts and the FDA are still reviewing the evidence.
Do I need to stop taking my GLP-1 to file a claim?
Medical decisions should be made with your doctor.
Can I file if I bought a GLP-1 online?
Possibly. It may depend on the product’s source and whether it was a brand-name drug or a compounded version. An attorney can review your records.
What compensation may be available?
Depending on the facts, a claim may seek medical expenses, lost income, future care costs and pain and suffering. No outcome can be promised.
Will my case be part of the federal litigation?
Many GLP-1 cases are being consolidated in federal court. Whether yours would join that litigation can depend on where and how it is filed.
Talk With a Lawyer About Your GLP-1 Vision Loss
Losing your sight can change everything, from your job to the simple moments you once took for granted. If you developed NAION or other vision loss while taking a GLP-1 drug, you may have legal options. Call 800-337-7755 or contact us online for a free, confidential case review.












